These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
94 related items for PubMed ID: 10382996
21. Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure. Wolf WC, Yoshida H, Agata J, Chao L, Chao J. Kidney Int; 2000 Aug; 58(2):730-9. PubMed ID: 10916096 [Abstract] [Full Text] [Related]
22. Increased atrial natriuretic peptide mRNA expression in the kidney of diabetic rats. Shin SJ, Lee YJ, Tan MS, Hsieh TJ, Tsai JH. Kidney Int; 1997 Apr; 51(4):1100-5. PubMed ID: 9083275 [Abstract] [Full Text] [Related]
23. Mechanisms of the therapeutic effect of astragalus membranaceus on sodium and water retention in experimental heart failure. Ma J, Peng A, Lin S. Chin Med J (Engl); 1998 Jan; 111(1):17-23. PubMed ID: 10322646 [Abstract] [Full Text] [Related]
24. Restoration of renal responsiveness to atrial natriuretic peptide in experimental nephrotic syndrome by albumin infusion. Abassi Z, Weissman I, Karram T, Goltsman I, Hoffman A, Better OS, Winaver J. Am J Nephrol; 2013 Jan; 38(4):292-9. PubMed ID: 24080549 [Abstract] [Full Text] [Related]
25. Reduced natriuretic effect of atrial natriuretic peptide in nephrotic syndrome: a possible role of decreased cyclic guanosine monophosphate. Jespersen B, Eiskjaer H, Mogensen CE, Sørensen SS, Pedersen EB. Nephron; 1995 Jan; 71(1):44-53. PubMed ID: 8538848 [Abstract] [Full Text] [Related]
26. Atrial natriuretic peptide protects against cisplatin-induced acute kidney injury. Nojiri T, Hosoda H, Kimura T, Miura K, Ishikane S, Tokudome T, Shintani Y, Inoue M, Miyazato M, Okumura M, Kangawa K. Cancer Chemother Pharmacol; 2015 Jan; 75(1):123-9. PubMed ID: 25385303 [Abstract] [Full Text] [Related]
27. Pharmacological profile of HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin. I. Selective inhibition of the actions of natriuretic peptides in anesthetized rats. Sano T, Morishita Y, Matsuda Y, Yamada K. J Pharmacol Exp Ther; 1992 Feb; 260(2):825-31. PubMed ID: 1346647 [Abstract] [Full Text] [Related]
28. Captopril and ANP: changes in renal hemodynamics, glomerular-ANP receptors and guanylate cyclase activity in rats with heart failure. Lee RW, Raya TE, Michael U, Foster S, Meeks T, Goldman S. J Pharmacol Exp Ther; 1992 Jan; 260(1):349-54. PubMed ID: 1346164 [Abstract] [Full Text] [Related]
29. The effect of medetomidine, an alpha 2-adrenoceptor agonist, on plasma atrial natriuretic peptide levels, haemodynamics and renal excretory function in spontaneously hypertensive and Wistar-Kyoto rats. Ruskoaho H, Leppäluoto J. Br J Pharmacol; 1989 May; 97(1):125-32. PubMed ID: 2566350 [Abstract] [Full Text] [Related]
30. Adrenomedullin gene delivery attenuates hypertension, cardiac remodeling, and renal injury in deoxycorticosterone acetate-salt hypertensive rats. Dobrzynski E, Wang C, Chao J, Chao L. Hypertension; 2000 Dec; 36(6):995-1001. PubMed ID: 11116114 [Abstract] [Full Text] [Related]
31. Atrial natriuretic peptide modulates sodium and potassium-activated adenosine triphosphatase through a mechanism involving cyclic GMP and cyclic GMP-dependent protein kinase. Scavone C, Scanlon C, McKee M, Nathanson JA. J Pharmacol Exp Ther; 1995 Mar; 272(3):1036-43. PubMed ID: 7891313 [Abstract] [Full Text] [Related]
32. Chronic administration of phosphodiesterase type 5 inhibitor suppresses renal production of endothelin-1 in dogs with congestive heart failure. Yamamoto T, Wada A, Ohnishi M, Tsutamoto T, Fujii M, Matsumoto T, Takayama T, Wang X, Kurokawa K, Kinoshita M. Clin Sci (Lond); 2002 Aug; 103 Suppl 48():258S-262S. PubMed ID: 12193099 [Abstract] [Full Text] [Related]
33. The beneficial effect of atrial natriuretic peptide on cyclosporine nephrotoxicity. Capasso G, Rosati C, Ciani F, Giordano DR, Russo F, De Santo NG. Am J Hypertens; 1990 Mar; 3(3):204-10. PubMed ID: 2138899 [Abstract] [Full Text] [Related]
34. Neurohumoral mechanism in the natriuretic action of intracerebroventricular administration of renin. Zavala L, Barbella Y, Israel A. J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):39-44. PubMed ID: 15136973 [Abstract] [Full Text] [Related]
35. Increased cyclic guanosine monophosphate production and overexpression of atrial natriuretic peptide A-receptor mRNA in spontaneously hypertensive rats. Tremblay J, Huot C, Willenbrock RC, Bayard F, Gossard F, Fujio N, Koch C, Kuchel O, Debinski W, Hamet P. J Clin Invest; 1993 Nov; 92(5):2499-508. PubMed ID: 7901238 [Abstract] [Full Text] [Related]
36. Renal function after myocardial infarction and cardiac arrest in rats: role of ANP-induced albuminuria? Nielsen SH, Magid E, Spannow J, Christensen S, Lam HR, Petersen JS. Acta Physiol Scand; 1997 Aug; 160(4):301-10. PubMed ID: 9338510 [Abstract] [Full Text] [Related]
37. Atrial natriuretic peptide transcription, secretion, and glomerular receptor activity during mineralocorticoid escape in the rat. Ballermann BJ, Bloch KD, Seidman JG, Brenner BM. J Clin Invest; 1986 Sep; 78(3):840-3. PubMed ID: 3018046 [Abstract] [Full Text] [Related]
38. Atrial natriuretic peptide attenuates kidney-lung crosstalk in kidney injury. Tulafu M, Mitaka C, Hnin Si MK, Abe S, Kitagawa M, Ikeda S, Eishi Y, Kurata S, Tomita M. J Surg Res; 2014 Jan; 186(1):217-25. PubMed ID: 23953791 [Abstract] [Full Text] [Related]
39. Corin is down-regulated and exerts cardioprotective action via activating pro-atrial natriuretic peptide pathway in diabetic cardiomyopathy. Pang A, Hu Y, Zhou P, Long G, Tian X, Men L, Shen Y, Liu Y, Cui Y. Cardiovasc Diabetol; 2015 Oct 07; 14():134. PubMed ID: 26446774 [Abstract] [Full Text] [Related]
40. Kinetics and pharmacodynamics of atrial natriuretic peptide and lithium clearance in the isolated perfused rat kidney. Brier ME, Brier RA, Luft FC, Aronoff GR. J Pharmacol Exp Ther; 1987 Dec 07; 243(3):868-73. PubMed ID: 2961879 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]